OPEN Versus InTact Capsule Proton Pump Inhibitors for the Treatment of Marginal Ulcers
NCT05799105
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
122
Enrollment
OTHER
Sponsor class
Conditions
Marginal Ulcer
Interventions
DRUG:
Omeprazole 40 milligrams
Sponsor
Stephen Firkins